Investing.com - GlaxoSmithKline ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline ADR announced earnings per share of £0.8279 on revenue of £12.34B. Analysts polled by Investing.com anticipated EPS of £0.7613 on revenue of £11.73B.
GlaxoSmithKline ADR shares are up 0.66% from the beginning of the year and are trading at £44.39 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on April 19, who reported EPS of £2.67 on revenue of £23.43B, compared to forecasts EPS of £2.59 on revenue of £23.62B.
UnitedHealth had beat expectations on April 14 with first quarter EPS of £5.49 on revenue of £80.15B, compared to forecast for EPS of £5.36 on revenue of £78.73B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar